Onconova Therapeutics Announces Initiation Of Phase 1 Clinical Trial Of ON 123300 In China By Partner HanX Biopharmaceuticals; Co Says Remains On Track To File U.S. IND In Q4 2020 With Phase 1 Set For Q1 2021
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.